Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead
2011

Drug Resistance in Tuberculosis Patients in Jiangsu, China

Sample size: 1824 publication 10 minutes Evidence: high

Author Information

Author(s): Shao Yan, Yang Dandan, Xu Weiguo, Lu Wei, Song Honghuan, Dai Yaoyao, Shen Hongbing, Wang Jianming

Primary Institution: Nanjing Medical University

Hypothesis

What are the current patterns and prevalence of anti-tuberculosis drug resistance in Jiangsu province?

Conclusion

The study found a high prevalence of drug resistance among tuberculosis patients in Jiangsu, highlighting significant challenges for TB control.

Supporting Evidence

  • 59.05% of MTB strains were sensitive to all tested antibiotics.
  • 40.95% of strains were resistant to at least one drug.
  • The prevalence of MDR-TB was 16.61%, significantly higher in previously treated cases.

Takeaway

This study looked at how many tuberculosis patients in Jiangsu, China, are resistant to common medicines, and found that many are, which makes treating them harder.

Methodology

The study collected strains from 1824 TB patients and tested them for drug susceptibility using standard methods.

Potential Biases

Misclassification of treatment history and sampling method limitations.

Limitations

Potential bias in estimating drug resistance in previously treated cases and lack of second-line drug testing.

Participant Demographics

Most participants were Han Chinese, with an average age of 50.8 years, and a sex ratio of 2.7 (men to women).

Statistical Information

P-Value

<0.001

Confidence Interval

1.88(1.26-2.81)

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2458-11-110

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication